Trials / Conditions / Polycystic Liver Disease

Polycystic Liver Disease

16 registered clinical trials studyying Polycystic Liver Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepat NCT05500157	Radboud University Medical Center	N/A
Active Not Recruiting	A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD NCT05281328	Camurus AB	Phase 2 / Phase 3
Recruiting	A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease NCT05478083	University Medical Center Groningen	Phase 2
Recruiting	Polycystic Liver Disease Registry (UK) NCT04645251	Portsmouth Hospitals NHS Trust	—
Unknown	The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Di NCT05215964	National Taiwan University Hospital	—
Unknown	Automatic Segmentation of Polycystic Liver NCT03960710	Hospices Civils de Lyon	—
Completed	Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q). NCT02173080	Mayo Clinic	—
Completed	Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease NCT02021110	Radboud University Medical Center	Phase 2
Completed	Pasireotide LAR in Severe Polycystic Liver Disease NCT01670110	Mayo Clinic	Phase 2
Completed	Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE) NCT01354405	Radboud University Medical Center	—
Completed	Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease NCT01315795	Universitaire Ziekenhuizen KU Leuven	Phase 2 / Phase 3
Completed	Everolimus and LongActing Octreotide Trial in Polycystic Livers NCT01157858	Radboud University Medical Center	Phase 2
Terminated	Polycystic Liver Disease in Kidney Transplant NCT00934791	Mayo Clinic	N/A
Unknown	Open-Label Extension of LOCKCYST Trial NCT00771888	Radboud University Medical Center	Phase 2 / Phase 3
Completed	Lanreotide as Treatment of Polycystic Livers NCT00565097	Radboud University Medical Center	Phase 2 / Phase 3
Completed	Octreotide in Severe Polycystic Liver Disease NCT00426153	Mayo Clinic	Phase 2 / Phase 3